Oncology-focused biotechnology developer Immunocore has raised the largest ever funding round by a European private life sciences company.
UK-based Immunocore raised $320m yesterday in a funding round backed by investors including pharmaceutical firm Eli Lilly and Company that stands as the largest ever raised by a European private life sciences company.
In addition to Eli Lilly, the oversubscribed round also featured fund manager Woodford Investment Management, healthcare investment firms Malin Corporation and RTW Investments, and undisclosed new and existing investors.
Founded in 2008 by Germany-based biotechnology company MediGene, which held an initial 38.5% stake, and three private investors,…
